Search research articles
Contact Us
Filters
Showing results (21-30 of 33) with videos related to
Page
of 4
Sort By:
Diabetes Technology & Therapeutics
|
January 31, 2017
Glucose Outcomes with the In-Home Use of a Hybrid Closed-Loop Insulin Delivery System in Adolescents and Adults with Type 1 Diabetes
Satish K Garg, Stuart A Weinzimer, William V Tamborlane, et al.
Diabetes Care
|
June 27, 2013
Feasibility of outpatient fully integrated closed-loop control: first studies of wearable artificial pancreas
Boris P Kovatchev, Eric Renard, Claudio Cobelli, et al.
Diabetes Technology & Therapeutics
|
May 17, 2019
Hybrid Closed-Loop Control Is Safe and Effective for People with Type 1 Diabetes Who Are at Moderate to High Risk for Hypoglycemia
Stacey M Anderson, Bruce A Buckingham, Marc D Breton, et al.
Diabetes Care
|
January 16, 2020
Randomized Controlled Trial of Mobile Closed-Loop Control
Boris Kovatchev, Stacey M Anderson, Dan Raghinaru, et al.
Diabetes Care
|
April 5, 2020
Erratum. Randomized Controlled Trial of Mobile Closed-Loop Control. Diabetes Care 2020;43:607-615
Boris Kovatchev, Stacey M Anderson, Dan Raghinaru, et al.
Diabetes Technology & Therapeutics
|
January 17, 2019
The International Diabetes Closed-Loop Study: Testing Artificial Pancreas Component Interoperability
Stacey M Anderson, Eyal Dassau, Dan Raghinaru, et al.
The New England Journal of Medicine
|
October 17, 2019
Six-Month Randomized, Multicenter Trial of Closed-Loop Control in Type 1 Diabetes
Sue A Brown, Boris P Kovatchev, Dan Raghinaru, et al.
Diabetes Care
|
June 16, 2014
Safety of outpatient closed-loop control: first randomized crossover trials of a wearable artificial pancreas
Boris P Kovatchev, Eric Renard, Claudio Cobelli, et al.
The Journal of Clinical Endocrinology and Metabolism
|
July 2, 2017
Overnight Closed-Loop Control Improves Glycemic Control in a Multicenter Study of Adults With Type 1 Diabetes
Sue A Brown, Marc D Breton, Stacey M Anderson, et al.
Diabetes Technology & Therapeutics
|
December 17, 2016
Feasibility of Long-Term Closed-Loop Control: A Multicenter 6-Month Trial of 24/7 Automated Insulin Delivery
Boris Kovatchev, Peiyao Cheng, Stacey M Anderson, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 33) with videos related to
Sort By:
Page
of 4
Diabetes Technology & Therapeutics
|
January 31, 2017
Glucose Outcomes with the In-Home Use of a Hybrid Closed-Loop Insulin Delivery System in Adolescents and Adults with Type 1 Diabetes
Satish K Garg, Stuart A Weinzimer, William V Tamborlane, et al.
Diabetes Care
|
June 27, 2013
Feasibility of outpatient fully integrated closed-loop control: first studies of wearable artificial pancreas
Boris P Kovatchev, Eric Renard, Claudio Cobelli, et al.
Diabetes Technology & Therapeutics
|
May 17, 2019
Hybrid Closed-Loop Control Is Safe and Effective for People with Type 1 Diabetes Who Are at Moderate to High Risk for Hypoglycemia
Stacey M Anderson, Bruce A Buckingham, Marc D Breton, et al.
Diabetes Care
|
January 16, 2020
Randomized Controlled Trial of Mobile Closed-Loop Control
Boris Kovatchev, Stacey M Anderson, Dan Raghinaru, et al.
Diabetes Care
|
April 5, 2020
Erratum. Randomized Controlled Trial of Mobile Closed-Loop Control. Diabetes Care 2020;43:607-615
Boris Kovatchev, Stacey M Anderson, Dan Raghinaru, et al.
Diabetes Technology & Therapeutics
|
January 17, 2019
The International Diabetes Closed-Loop Study: Testing Artificial Pancreas Component Interoperability
Stacey M Anderson, Eyal Dassau, Dan Raghinaru, et al.
The New England Journal of Medicine
|
October 17, 2019
Six-Month Randomized, Multicenter Trial of Closed-Loop Control in Type 1 Diabetes
Sue A Brown, Boris P Kovatchev, Dan Raghinaru, et al.
Diabetes Care
|
June 16, 2014
Safety of outpatient closed-loop control: first randomized crossover trials of a wearable artificial pancreas
Boris P Kovatchev, Eric Renard, Claudio Cobelli, et al.
The Journal of Clinical Endocrinology and Metabolism
|
July 2, 2017
Overnight Closed-Loop Control Improves Glycemic Control in a Multicenter Study of Adults With Type 1 Diabetes
Sue A Brown, Marc D Breton, Stacey M Anderson, et al.
Diabetes Technology & Therapeutics
|
December 17, 2016
Feasibility of Long-Term Closed-Loop Control: A Multicenter 6-Month Trial of 24/7 Automated Insulin Delivery
Boris Kovatchev, Peiyao Cheng, Stacey M Anderson, et al.
Page
of 4